Sri Sri Holistic Hospitals is proud to announce the launch of India's first revolutionary Pulse Field Ablation (PFA) ...

CARDAMYST™ (etripamil) nasal spray launch for PSVT is gaining traction; breadth of unique prescribers supports potential future adoptionExpress ...

The ACC, AHA, and HRS have released the 2026 advanced training statement on clinical cardiac electrophysiology.

Milestone Pharmaceuticals (NASDAQ:MIST) said its first quarter of 2026 marked the beginning of commercial sales for CARDEMYST ...

Hengrui Pharma (Hengrui) and Braveheart Bio (Braveheart) today announced results from a multi-center, randomized, double-blind, placebo-controlled Phase 2 study evaluating HRS-1893 (also known as ...

Multinational Real-world Data Reinforce Favorable Clinical Profile and Long-Term Safety SOUTH SAN FRANCISCO, Calif., May 11, 2026 (GLOBE ...

As of Wednesday, May 13, Milestone Pharmaceuticals Inc.’s MIST share price has dipped by 8.42%, which has investors ...

With the paid subscription, you also get additional benefits such as cloud storage, blood pressure monitoring, medication ...

At the Heart Rhythm Society’s 2026 meeting, Medtronic, Boston Scientific, Abbott, and others unveiled strong trial results for next-generation arrhythmia treatment devices, particularly pulsed field ...

It's essential to seek emergency care if a rapid heartbeat is paired with confusion or chest pain. ER treatments for tachycardia include medications and electrical cardioversion. Managing stress and ...

Medtronic announces key Affera clinical study milestones for Sphere-9 and Sphere-360 catheters as global adoption continues: Galway, Ireland Tuesday, April 28, 2026, 11:00 Hrs [IS ...